FI923662L - Terapeutiska medel - Google Patents
Terapeutiska medel Download PDFInfo
- Publication number
- FI923662L FI923662L FI923662A FI923662A FI923662L FI 923662 L FI923662 L FI 923662L FI 923662 A FI923662 A FI 923662A FI 923662 A FI923662 A FI 923662A FI 923662 L FI923662 L FI 923662L
- Authority
- FI
- Finland
- Prior art keywords
- therapeutic medicine
- therapeutic
- medicine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919117644A GB9117644D0 (en) | 1991-08-15 | 1991-08-15 | Amine derivatives |
| GB929207539A GB9207539D0 (en) | 1992-04-07 | 1992-04-07 | Therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI923662A0 FI923662A0 (fi) | 1992-08-14 |
| FI923662L true FI923662L (fi) | 1993-02-16 |
Family
ID=26299413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI923662A FI923662L (fi) | 1991-08-15 | 1992-08-14 | Terapeutiska medel |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US5399568A (ko) |
| EP (1) | EP0532177B1 (ko) |
| JP (1) | JP3281047B2 (ko) |
| KR (1) | KR100233209B1 (ko) |
| AT (1) | ATE144252T1 (ko) |
| AU (1) | AU652653B2 (ko) |
| CA (1) | CA2076168A1 (ko) |
| CZ (1) | CZ251892A3 (ko) |
| DE (1) | DE69214586T2 (ko) |
| DK (1) | DK0532177T3 (ko) |
| ES (1) | ES2092645T3 (ko) |
| FI (1) | FI923662L (ko) |
| GB (1) | GB9216297D0 (ko) |
| GR (1) | GR3021399T3 (ko) |
| HU (1) | HUT66623A (ko) |
| IE (1) | IE922587A1 (ko) |
| IL (1) | IL102806A0 (ko) |
| NO (1) | NO923198L (ko) |
| NZ (1) | NZ243954A (ko) |
| TW (1) | TW222622B (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9216298D0 (en) * | 1991-08-15 | 1992-09-16 | Ici Plc | Piperidine derivatives |
| US5514683A (en) * | 1992-02-20 | 1996-05-07 | James Black Foundation Limited | Bicyclo 2,2,2!octane derivatives |
| US5530012A (en) * | 1994-12-22 | 1996-06-25 | Bristol-Myers Squibb Co. | 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
| US5728712A (en) * | 1995-05-19 | 1998-03-17 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
| US20070225217A1 (en) | 2005-11-09 | 2007-09-27 | Combinatorx, Incorporated | Methods, compositions, and kits for the treatment of medical conditions |
| JP2010526130A (ja) * | 2007-05-09 | 2010-07-29 | ファイザー・インク | 置換ヘテロ環式誘導体ならびにそれらの医薬使用および組成物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3632653A (en) * | 1960-11-29 | 1972-01-04 | Ciba Geigy Corp | Ethano-anthracenes |
| BE610863A (fr) * | 1960-11-29 | 1962-05-28 | Ciba Geigy | Procédé de préparation de nouvelles amines, entre autres de 9-amino-alcoyl-9,10-dihydro-9,10-éthano-(1,2)-anthracènes |
| NL127069C (ko) * | 1961-10-10 | |||
| FR176F (ko) * | 1965-05-19 | |||
| US3489799A (en) * | 1967-09-26 | 1970-01-13 | Ciba Geigy Corp | Ethano-anthracenes |
| ES367292A1 (es) * | 1968-05-16 | 1971-05-01 | Ciba Geigy | Procedimiento para la obtencion de 9-(aminoalquilo)-9,10- dihidro - 9,10-etanoantracenos sustituidos. |
| CH539602A (de) * | 1969-03-25 | 1973-09-14 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen N-substituierten 9-(Aminoalkyl)-9,10-dihydro-9,10-äthano-anthrazenen |
| US3706765A (en) * | 1969-01-03 | 1972-12-19 | Ciba Geigy Corp | Hydroxyethano-anthracenes |
| DE2021668A1 (de) * | 1969-05-10 | 1970-11-19 | Ciba Geigy | Neue Amine und Verfahren zu ihrer Herstellung |
| US3870796A (en) * | 1970-11-27 | 1975-03-11 | Ciba Geigy Corp | Pharmaceutical preparation |
| US4045580A (en) * | 1971-02-23 | 1977-08-30 | Ciba-Geigy Corporation | Pharmaceutical preparation using 9-(2-hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes as antidepressants |
| US4017542A (en) * | 1971-02-23 | 1977-04-12 | Ciba-Geigy Corporation | 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and salts thereof |
| JPS5911576B2 (ja) * | 1975-07-07 | 1984-03-16 | 住友化学工業株式会社 | 新規なメタノ−アントラセン誘導体の製造法 |
| US4358620A (en) * | 1974-12-13 | 1982-11-09 | Sumitomo Chemical Company, Limited | 9-Formyl-9,10-dihydro-9,10-methanoanthracene |
| US4224344A (en) * | 1974-12-13 | 1980-09-23 | Sumitomo Chemical Company, Limited | Organic tricyclic compounds |
| JPS527972A (en) * | 1975-07-07 | 1977-01-21 | Sumitomo Chem Co Ltd | Process for preparing novel morpholine derivatives |
| JPS5268170A (en) * | 1975-12-03 | 1977-06-06 | Sumitomo Chem Co Ltd | Preparation of novel methano-anthracene derivatives |
| GB1531278A (en) * | 1975-12-15 | 1978-11-08 | Shionogi & Co | 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof |
| JPS5910654B2 (ja) * | 1976-04-07 | 1984-03-10 | 住友化学工業株式会社 | 新規なメタノ−アントラセン誘導体 |
| JPS5936621B2 (ja) * | 1976-05-19 | 1984-09-05 | 大塚製薬株式会社 | 新規なカルボスチリル誘導体 |
| US4318926A (en) * | 1979-08-14 | 1982-03-09 | Ciba-Geigy Corporation | Method of curing or alleviating herpes infections and pharmaceutical compositions suitable therefor |
| US5226570A (en) * | 1991-07-16 | 1993-07-13 | Fabio Pedrini | Self-centering roof rack |
| GB9117639D0 (en) * | 1991-08-15 | 1991-10-02 | Ici Plc | Therapeutic compounds |
| GB9216298D0 (en) * | 1991-08-15 | 1992-09-16 | Ici Plc | Piperidine derivatives |
| JP3005175U (ja) | 1993-08-23 | 1994-12-13 | 有限会社サンエイ | レンタルショップ用ビデオケース |
-
1992
- 1992-07-31 GB GB929216297A patent/GB9216297D0/en active Pending
- 1992-08-06 US US07/927,685 patent/US5399568A/en not_active Expired - Lifetime
- 1992-08-11 EP EP92307352A patent/EP0532177B1/en not_active Expired - Lifetime
- 1992-08-11 ES ES92307352T patent/ES2092645T3/es not_active Expired - Lifetime
- 1992-08-11 DK DK92307352.2T patent/DK0532177T3/da active
- 1992-08-11 DE DE69214586T patent/DE69214586T2/de not_active Expired - Lifetime
- 1992-08-11 AT AT92307352T patent/ATE144252T1/de not_active IP Right Cessation
- 1992-08-14 HU HU9202641A patent/HUT66623A/hu unknown
- 1992-08-14 CZ CS922518A patent/CZ251892A3/cs unknown
- 1992-08-14 NZ NZ243954A patent/NZ243954A/en unknown
- 1992-08-14 IL IL102806A patent/IL102806A0/xx unknown
- 1992-08-14 AU AU21017/92A patent/AU652653B2/en not_active Ceased
- 1992-08-14 CA CA002076168A patent/CA2076168A1/en not_active Abandoned
- 1992-08-14 FI FI923662A patent/FI923662L/fi unknown
- 1992-08-14 JP JP21699592A patent/JP3281047B2/ja not_active Expired - Lifetime
- 1992-08-14 KR KR1019920014635A patent/KR100233209B1/ko not_active Expired - Fee Related
- 1992-08-14 NO NO92923198A patent/NO923198L/no unknown
- 1992-08-14 IE IE258792A patent/IE922587A1/en unknown
- 1992-08-19 TW TW081106563A patent/TW222622B/zh active
-
1995
- 1995-01-19 US US08/374,053 patent/US5550136A/en not_active Expired - Lifetime
-
1996
- 1996-04-15 US US08/632,705 patent/US5719166A/en not_active Expired - Lifetime
- 1996-10-17 GR GR960402635T patent/GR3021399T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05246988A (ja) | 1993-09-24 |
| US5399568A (en) | 1995-03-21 |
| AU2101792A (en) | 1993-02-18 |
| JP3281047B2 (ja) | 2002-05-13 |
| GB9216297D0 (en) | 1992-09-16 |
| NO923198L (no) | 1993-02-16 |
| US5719166A (en) | 1998-02-17 |
| DE69214586T2 (de) | 1997-03-20 |
| FI923662A0 (fi) | 1992-08-14 |
| DK0532177T3 (da) | 1997-03-24 |
| AU652653B2 (en) | 1994-09-01 |
| NO923198D0 (no) | 1992-08-14 |
| HUT66623A (en) | 1994-12-28 |
| DE69214586D1 (de) | 1996-11-21 |
| ES2092645T3 (es) | 1996-12-01 |
| KR100233209B1 (ko) | 1999-12-01 |
| KR930004234A (ko) | 1993-03-22 |
| CZ251892A3 (en) | 1993-02-17 |
| IL102806A0 (en) | 1993-01-31 |
| ATE144252T1 (de) | 1996-11-15 |
| GR3021399T3 (en) | 1997-01-31 |
| HU9202641D0 (en) | 1992-10-28 |
| IE922587A1 (en) | 1993-02-24 |
| TW222622B (ko) | 1994-04-21 |
| EP0532177A1 (en) | 1993-03-17 |
| EP0532177B1 (en) | 1996-10-16 |
| CA2076168A1 (en) | 1993-02-16 |
| US5550136A (en) | 1996-08-27 |
| NZ243954A (en) | 1995-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI923379L (fi) | Terapeutiska amider | |
| FI924035A (fi) | Nya 5-amino-4-hydroxihexansyraderivat saosom terapeutiska medel | |
| FI934964L (fi) | Teraupetiskt aemne | |
| FI935878L (fi) | Porfycenfoereningar foer fotodynamisk terapi | |
| DK0616523T3 (da) | Lægemidler | |
| FI922785L (fi) | Terapeutiska preparat | |
| DE59209635D1 (de) | Herztherapiesystem | |
| FI924456L (fi) | Laekemedel | |
| KR950700754A (ko) | 신규의 약물(novel medicament) | |
| FI924069L (fi) | Terapeutiskt anvaendbara peptider och peptidfragment | |
| DE69224941D1 (de) | Arzneimittelabgabekatheter | |
| DK0515312T3 (da) | Farmaceutisk præparat | |
| DE59209096D1 (de) | Mikrobizide Wirkstoffkombinationen | |
| FI934194L (fi) | Kontrastmedel | |
| DK0507513T3 (da) | Terapeutisk anordning | |
| FI924744L (fi) | Terapeutiska aemnen | |
| FI922238A (fi) | Stoed foer terapeutisk magnet | |
| FI934228L (fi) | Tvaerbindande medel | |
| FI923759L (fi) | Terapeutiska bensazapinfoereningar | |
| FI930674A0 (fi) | Terapeutiska aemnen | |
| FI923662L (fi) | Terapeutiska medel | |
| BG96715A (bg) | Терапевтични вещества | |
| NO306381B1 (no) | Farmasöytisk ampulle | |
| DE59207408D1 (de) | Mikrobizide Wirkstoffkombinationen | |
| FI931071A0 (fi) | Terapeutiska aemnen |